CAR-T cell production
DOI:
https://doi.org/10.46765/2675-374X.2022v3n1p155Keywords:
CAR-T cells, GMP manufacturing, viral vector, genetic modificationAbstract
Cell therapy with T cells expressing chimeric antigen receptor (CAR-T) is a type of immunotherapy that involves the manipulation and reprogramming of immune cells (T lymphocytes) in order to recognize and kill tumor cells. For use in patients, CAR-T cells must be manufcatured inside a GMP facility according to a established procedure.
Downloads
Published
04/24/2022
How to Cite
Bonamino, M. ., Melo Alves Paiva, R., Preto de Godoy, J., Tiemi Kondo, A., Keith Okamoto, O., & Nassif Kerbauy, L. (2022). CAR-T cell production. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 3(1), 155. https://doi.org/10.46765/2675-374X.2022v3n1p155
Issue
Section
Original article
License
Copyright (c) 2022 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.